Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Clinical Trial

Comparative Study

Research Support, U.S. Gov't, P.H.S.

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2013

2005

2004

2003

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""HLA-A24 Antigen""[mesh_terms]

8 Results

Searching titles within these results

Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.

John Sidney, Scott Southwood, Alessandro Sette

Immunogenetics 2005;57(6):393-408

Full Text

Abstract

Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.

Shoko Tanaka, Mamoru Harada, Takashi Mine, Masanori Noguchi, Rumi Gohara, Koichi Azuma, Mayumi Tamura, Akira Yamada, Akiko Morinaga, Misa Nishikori, Kazuko Katagiri, Kyogo Itoh, Hideaki Yamana, Takashi Hashimoto

Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;26(4):357-66

Full Text

Abstract

Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer.

Koutaro Yamamoto, Takashi Mine, Kazuko Katagiri, Nobuaki Suzuki, Toru Kawaoka, Tomio Ueno, Satoko Matsueda, Akira Yamada, Kyogo Itoh, Hideaki Yamana, Masaaki Oka

Oncology reports 2005;13(5):874-83

Full Text

Abstract

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

Masaru Murai, Kazutoh Takesako, Masaaki Tachibana, Allesandro Sette, John Fikes, Kazuhide Okazawa, Ikuei Nukaya, Yutaka Horiguchi, Ichiro Kawashima

Clinical cancer research : an official journal of the American Association for Cancer Research 2003;8(12):3885-92

Full Text

Abstract

A combined bioinformatic approach oriented to the analysis and design of peptides with high affinity to MHC class I molecules.

Tabea Hennig, Carlos A Del Carpio, Atsushi Yoshimori, Simonetta Fickel

Immunology and cell biology 2003;80(3):286-99

Full Text

Abstract

Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.

Hiroshi Yamaguchi, Fumiaki Tanaka, Mitsuhiko Ohta, Hiroshi Inoue, Masaki Mori

Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):890-6

Full Text

Abstract

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Yoshiyuki Yamaguchi, Koji Ohta, Yoshiharu Kawabuchi, Akiko Ohshita, Riki Okita, Makoto Okawaki, Katsuji Hironaka, Kazuo Matsuura, Tetsuya Toge

Anticancer research 2005;25(3c):2407-15

Free Full Text

Abstract

Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma.

Norihiko Tsuchiya, Shintaro Narita, Takamitsu Inoue, Naoko Hasunuma, Kazuyuki Numakura, Yohei Horikawa, Shigeru Satoh, Takeshi Notoya, Naohito Fujishima, Shingo Hatakeyama, Chikara Ohyama, Tomonori Habuchi

Anti-cancer drugs 2013;24(3):310-4

Full Text

Abstract

Results: 1 – 8 / 8

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""HLA-A24 Antigen""[mesh_terms]

Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires.

Peptide vaccination for patients with melanoma and other types of cancer based on pre-existing peptide-specific ctotoxic T-lymphocyte precursors in the periphery.

Immunological evaluation of personalized peptide vaccination for patients with pancreatic cancer.

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

A combined bioinformatic approach oriented to the analysis and design of peptides with high affinity to MHC class I molecules.

Identification of HLA-A24-restricted CTL epitope from cancer-testis antigen, NY-ESO-1, and induction of a specific antitumor immune response.

Feasibility study of adoptive immunotherapy for metastatic lung tumors using peptide-pulsed dendritic cell-activated killer (PDAK) cells.

Risk factors for sorafenib-induced high-grade skin rash in Japanese patients with advanced renal cell carcinoma.

Results for
""HLA-A24 Antigen""[mesh_terms]